Halma, the FTSE 100 group of life-saving technology companies, announces that it is hosting an event for analysts and institutional investors today, focused on the Group's Infrastructure Safety sector.
The event will include a presentation by Infrastructure Safety sector senior management which will describe the sector's strong competitive positions in its markets, and how the sector is delivering sustainable growth, supported by long‐term growth drivers and Halma's Growth Enablers. There will also be breakout sessions which will showcase sector companies and recent innovation.
No new material financial information will be disclosed and there will be no update on current trading. The next scheduled update on trading will be on 19 March 2020, in line with the Group's normal reporting timetable.
The presentation will be available on Halma's website, www.halma.com, following the event.
|
For further information, please contact:
|
|
|
Halma plc |
|
|
Andrew Williams, Chief Executive |
Switchboard: +44 (0)1494 721111 |
|
Marc Ronchetti, Chief Financial Officer |
|
|
Charles King, Head of Investor Relations |
Mobile: +44 (0)7776 685948 |
|
MHP Communications |
|
|
Rachel Hirst/ Andrew Jaques |
+44 (0)20 3128 8752 |
About Halma
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner and healthier future for people worldwide. Our innovative products and solutions address many of the key issues facing the world today. We operate in four sectors: Process Safety, Infrastructure Safety, Medical and Environmental & Analysis. We employ over 6,000 people in more than 20 countries, with major operations in Europe, the USA and Asia-Pacific. We target global niche markets where sustainable growth and high returns are supported by long-term drivers. Halma is listed on the London Stock Exchange and is a member of the FTSE 100 index.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
